Corpus ID: 220936227

What can we learn about SARS-CoV-2 prevalence from testing and hospital data?

@article{Sacks2020WhatCW,
  title={What can we learn about SARS-CoV-2 prevalence from testing and hospital data?},
  author={Daniel W Sacks and N. Menachemi and P. Embi and Coady Wing},
  journal={arXiv: Econometrics},
  year={2020}
}
Measuring the prevalence of active SARS-CoV-2 infections is difficult because tests are conducted on a small and non-random segment of the population. But people admitted to the hospital for non-COVID reasons are tested at very high rates, even though they do not appear to be at elevated risk of infection. This sub-population may provide valuable evidence on prevalence in the general population. We estimate upper and lower bounds on the prevalence of the virus in the general population and the… Expand
How many people are infected? A case study on SARS-CoV-2 prevalence in Austria
Using recent data from voluntary mass testing, I provide credible bounds on prevalence of SARS-CoV-2 for Austrian counties in early December 2020. When estimating prevalence, a natural missing dataExpand
Estimating the cumulative rate of SARS-CoV-2 infection
TLDR
A simple and easy-to-use Bayesian model is proposed to estimate the infection rate of SARS-CoV-2, based on the mapping from the fraction of positive test results to the cumulative infection rate, which depends on two unknown quantities. Expand
Bounding Disease Prevalence by Bounding Selectivity and Accuracy of Tests: The Case of COVID-19
I propose novel partial identification bounds on disease prevalence from information on test rate and test yield. The approach broadly follows recent work by \cite{MM20} on COVID-19, but starts fromExpand
Binary Classification Tests, Imperfect Standards, and Ambiguous Information
New binary classification tests are often evaluated relative to a preestablished test. For example, rapid Antigen tests for the detection of SARS-CoV-2 are assessed relative to more established PCRExpand

References

SHOWING 1-10 OF 43 REFERENCES
Population Point Prevalence of SARS-CoV-2 Infection Based on a Statewide Random Sample — Indiana, April 25–29, 2020
TLDR
Given the large number of persons who remain susceptible in Indiana, adherence to evidence-based public health mitigation and containment measures is needed to reduce surge in hospitalizations and prevent morbidity and mortality from COVID-19. Expand
Estimates of the Undetected Rate among the SARS-CoV-2 Infected using Testing Data from Iceland
TLDR
The share of infections that are undetected under standard (NUHI) testing guidelines is estimated from 88.7% to 93.6% based on results from COVID-19 testing data from Iceland. Expand
Identification and Estimation of Undetected Covid-19 Cases Using Testing Data from Iceland
TLDR
It is shown that partial identification techniques can credibly deal with the data problems that common COVID-19 testing programs induce and that the undetected rate was between 89% and 93% before the medical system broadened its eligibility criteria and between 80% and 90% after. Expand
Spread of SARS-CoV-2 in the Icelandic Population
TLDR
In a population-based study in Iceland, children under 10 years of age and females had a lower incidence of SARS-CoV-2 infection than adolescents or adults and males and the proportion of infected participants identified through population screening remained stable for the 20-day duration of screening. Expand
Estimating the burden of SARS-CoV-2 in France
TLDR
France has been heavily affected by the SARS-CoV-2 epidemic and went into lockdown on the 17th March 2020, and population immunity appears insufficient to avoid a second wave if all control measures are released at the end of the lockdown. Expand
Estimating the effects of non-pharmaceutical interventions on COVID-19 in Europe
TLDR
The results show that major non-pharmaceutical interventions and lockdown in particular have had a large effect on reducing transmission and continued intervention should be considered to keep transmission of SARS-CoV-2 under control. Expand
Estimates of the severity of coronavirus disease 2019: a model-based analysis
TLDR
These early estimates give an indication of the fatality ratio across the spectrum of COVID-19 disease and show a strong age gradient in risk of death. Expand
Performance of Rapid Influenza Diagnostic Testing in Outbreak Settings
TLDR
Evaluating the performance of RIDTs in comparison with that of real-time reverse transcription (rRT)-PCR in the context of institutional respiratory disease outbreaks found an overall sensitivity of 76.5%, a specificity of 99.7%, a positive predictive value (PPV) of 99, and a negative predictive value of 85.3%. Expand
Estimating the Covid-19 Infection Rate: Anatomy of an Inference Problem
TLDR
The logical problem of bounding rates of population infection by the SARS CoV-2 virus is explained and the infection rate in Illinois, New York, and Italy is found to be substantially higher than reported and that the infection fatality rate in Italy is substantially lower than reported. Expand
Estimating the infection and case fatality ratio for coronavirus disease (COVID-19) using age-adjusted data from the outbreak on the Diamond Princess cruise ship, February 2020
  • T. Russell, J. Hellewell, +7 authors A. Kucharski
  • Medicine
  • Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin
  • 2020
TLDR
Adjusting for delay from confirmation to death, case and infection fatality ratios (CFR, IFR) for coronavirus disease (COVID-19) on the Diamond Princess ship as 2.6% and 1.3% (95% confidence interval: 0.89–6.7) are estimated, respectively. Expand
...
1
2
3
4
5
...